Enzon Pharmaceuticals, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced total revenue was USD 8,000 compared to USD 207,000 a year ago. Operating loss was USD 236,000 compared to USD 21,000 a year ago. Net loss was USD 236,000 compared to USD 21,000 a year ago. Basic loss per share from continuing operations was USD 0.01. For the half year, total revenue was USD 10,000 compared to USD 156,000 a year ago. Operating loss was USD 476,000 compared to USD 390,000 a year ago. Net loss was USD 478,000 compared to USD 392,000 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.